Personalized Breast Cancer Treatment
21 – 30 of 148
                - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
        Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2023
- 
                        Mark
        Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Reply to V. Nardone et al
    
    - Contribution to journal › Debate/Note/Editorial
 
- 
                        Mark
        Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
    
    - Contribution to journal › Article
 
- 
                        Mark
        A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
    
    - Contribution to journal › Article
 
- 
                        Mark
        The implementation of NILS : A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer : a long-term follow-up of the SweBCG91RT randomized trial
    
    - Contribution to journal › Article
 
- 
                        Mark
        Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
    
    - Contribution to journal › Article
 
- 
                        Mark
        Proteogenomics decodes the evolution of human ipsilateral breast cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
    
    - Contribution to journal › Article
 
- 
                        Mark
        Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
    
    - Contribution to journal › Article
 
